1. Volume 125, Issue 4, Pages 1239-1247 (April 2004)
Clinical Similarities and Differences Between Human T-Cell Lymphotropic Virus Type 1- Associated Bronchiolitis and Diffuse Panbronchiolitis 
Jun-ichi Kadota, MD, PhD, Hiroshi Mukae, MD, PhD, Takeshi Fujii, MD, PhD, Masafumi Seki, MD, PhD, Kazunori Tomono, MD, PhD, Shigeru Kohno, MD, PhD, FCCP 
CHEST 
Volume 125, Issue 4, Pages (April 2004)
DOI: /chest
Copyright © 2004 The American College of Chest Physicians Terms and Conditions

2. Figure 1
Representative CT scans from patients with diffuse panbronchiolitis (top) and HTLV-1–associated bronchiolitis (bottom).
CHEST  , DOI: ( /chest )
Copyright © 2004 The American College of Chest Physicians Terms and Conditions

3. Figure 2
Ratios of CD3+CD25+ cells in BAL fluid obtained from patients with HTLV-1–associated bronchiolitis, diffuse panbronchiolitis, and healthy volunteers. Values are expressed as the mean ± SE. ○ = high IL-2R group of HTLV-1–associated bronchiolitis patients with > 15% CD3+CD25+ cells (horizontal bar).
CHEST  , DOI: ( /chest )
Copyright © 2004 The American College of Chest Physicians Terms and Conditions

4. Figure 3
Changes in Pao2 after macrolide treatment of patients with diffuse panbronchiolitis and HTLV-1–associated bronchiolitis. Values are expressed as the mean ± SE. ○ = high IL-2R group of HTLV-1–associated bronchiolitis patients; • = low IL-2R group of HTLV-1–associated bronchiolitis patients.
CHEST  , DOI: ( /chest )
Copyright © 2004 The American College of Chest Physicians Terms and Conditions

5. Figure 4
Changes in FEV1 after macrolide treatment of patients with diffuse panbronchiolitis and HTLV-1–associated bronchiolitis. Values are expressed as the mean ± SE. ○ = high IL-2R group of HTLV-1–associated bronchiolitis patients; • = low IL-2R group of HTLV-1–associated bronchiolitis patients.
CHEST  , DOI: ( /chest )
Copyright © 2004 The American College of Chest Physicians Terms and Conditions